{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:52:49Z","timestamp":1740174769020,"version":"3.37.3"},"reference-count":17,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To describe a case of a patient who developed psychosis after ingestion of Vertigoheel for treatment of dizziness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case Summary<\/jats:title>\n                  <jats:p>A 28-year-old male with no psychiatric history presented with 5 days of worsening depression and psychosis. He denied current use of prescription medications, alcohol, or illicit substances. Approximately 2 weeks prior, while visiting family in Germany, he developed dizziness. A provider in Germany prescribed Vertigoheel, 1 tablet to be taken every hour until symptom improvement. This did not improve his dizziness but did cause him to feel as if he were \u201cin a dream.\u201d He stopped taking the medication after 2 days but continued to feel amotivated with decreased appetite and insomnia. Several days later, he developed ego-dystonic auditory hallucinations. He returned to the United States; was admitted to an inpatient psychiatric unit for 4 days; and given olanzapine 5 mg at bedtime, lorazepam 1 mg every evening, and melatonin 6 mg every evening. He experienced gradual improvement in symptoms and was discharged with olanzapine 5 mg daily and outpatient follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Vertigoheel is a homeopathic preparation containing ambra grisea, Cocculus indicus, Conium maculatum, and petroleum. Psychosis was not reported in any of the randomized controlled trials evaluating the use of Vertigoheel for treatment of vertigo. A literature search revealed no published reports of psychosis as a result of administration of any components of Vertigoheel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A possible causal relationship was observed between the homeopathic supplement Vertigoheel and an acute episode of psychosis in a young male patient with no comorbidities.<\/jats:p>\n               <\/jats:sec>","DOI":"10.9740\/mhc.2021.01.031","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:48:57Z","timestamp":1610585337000},"page":"31-34","source":"Crossref","is-referenced-by-count":0,"title":["Vertigoheel induced psychosis: A patient case report"],"prefix":"10.9740","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-4178","authenticated-orcid":true,"given":"Megan","family":"O'Connell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2907-6394","authenticated-orcid":true,"given":"Elizabeth","family":"Hunt","sequence":"additional","affiliation":[{"name":"PGY-4 Psychiatry Resident, Michigan Medicine, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2294-2694","authenticated-orcid":true,"given":"Amy","family":"VandenBerg","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Specialist, Psychiatry and Neurology, Michigan Medicine, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"2021012100102935000_i2168-9709-11-1-31-b01","unstructured":"Vertigoheel by Heel, Inc (formerly known as BHI) [Internet].\n          TRC natural medicines\n          [cited\n          2019\n          Mar 18]. Available from: https:\/\/naturalmedicines-therapeuticresearch-com.proxy.lib.umich.edu\/."},{"key":"2021012100102935000_i2168-9709-11-1-31-b02","unstructured":"Vertigoheel [Internet].\n          Vertigoheel tablets\n          [cited\n          2020\n          Aug 24]. Available from: https:\/\/www.vertigoheel.com\/en\/vertigoheel-tablets.html"},{"key":"2021012100102935000_i2168-9709-11-1-31-b03","doi-asserted-by":"crossref","unstructured":"Hobbs\n              CA,\n            \n            \n              Saigo\n              K,\n            \n            \n              Koyanagi\n              M,\n            \n          \n          Hayashi S-mo. Magnesium stearate, a widely-used food additive, exhibits a lack of in vitro and in vivo genotoxic potential.\n\t\t\t\t\tToxicol Rep.\n\t\t\t\t\t2017;4:554-9.\n\t\t\t\t\tDOI: 10.1016\/j.toxrep.2017.10.003. PubMed PMID: 29090120; PubMed Central PMCID: PMC5655391.","DOI":"10.1016\/j.toxrep.2017.10.003"},{"key":"2021012100102935000_i2168-9709-11-1-31-b04","unstructured":"Amazon.com, Inc [Internet]. Vertigoheel\n          [cited\n          2020\n          Aug 24]. Available from: https:\/\/www.amazon.com\/Vertigoheel-N50-Treatment-Dizziness-Excercise\/dp\/B07ZVM9LDT\/ref=sr_1_2?dchild=1&keywords=vertigoheel&qid=1598311257&sr=8-2"},{"key":"2021012100102935000_i2168-9709-11-1-31-b05","doi-asserted-by":"crossref","unstructured":"Merrell\n              WC,\n            \n            \n              Shalts\n              E.\n            \n          \n          Homeopathy.\n\t\t\t\t\tMed Clin North Am.\n\t\t\t\t\t2002;86(1):47-62.\n\t\t\t\t\tDOI: 10.1016\/s0025-7125(03)00071-3. PubMed PMID: 11795090.","DOI":"10.1016\/S0025-7125(03)00071-3"},{"key":"2021012100102935000_i2168-9709-11-1-31-b06","doi-asserted-by":"crossref","unstructured":"Asher\n              BF,\n            \n            \n              Seidman\n              M,\n            \n            \n              Snyderman\n              C.\n            \n          \n          Complementary and alternative medicine in otolaryngology.\n\t\t\t\t\tLaryngoscope.\n\t\t\t\t\t2001;111(8):1383-9.\n\t\t\t\t\tDOI: 10.1097\/00005537-200108000-00013. PubMed PMID: 11568573.","DOI":"10.1097\/00005537-200108000-00013"},{"key":"2021012100102935000_i2168-9709-11-1-31-b07","doi-asserted-by":"crossref","unstructured":"Bause\n              GS.\n            \n          \n          From fish poison to merck picrotoxin.\n\t\t\t\t\tAnesthesiology.\n\t\t\t\t\t2013;118(6):1263.\n\t\t\t\t\tDOI: 10.1097\/ALN.0b013e31829a0b4b. PubMed PMID: 23695089.","DOI":"10.1097\/ALN.0b013e31829a0b4b"},{"key":"2021012100102935000_i2168-9709-11-1-31-b08","unstructured":"Conium maculatum [Internet].\n          Toxinz: poisons information\n          [cited\n          2019\n          Jun 24]. Available from: https:\/\/www.toxinz.com\/Demo\/6\/UExIMDIyLzEwNGg%3D"},{"key":"2021012100102935000_i2168-9709-11-1-31-b09","doi-asserted-by":"crossref","unstructured":"Erkent\n              U,\n            \n            \n              Iskit\n              AB,\n            \n            \n              Onur\n              R,\n            \n            \n              Ilhan\n              M.\n            \n          \n          The effect of coniine on presynaptic nicotinic receptors.\n\t\t\t\t\tZ Naturforsch C J Biosci.\n\t\t\t\t\t2016;71(5-6):115-20.\n\t\t\t\t\tDOI: 10.1515\/znc-2015-0194. PubMed PMID: 27107833.","DOI":"10.1515\/znc-2015-0194"},{"key":"2021012100102935000_i2168-9709-11-1-31-b10","doi-asserted-by":"crossref","unstructured":"Heinle\n              H,\n            \n            \n              Tober\n              C,\n            \n            \n              Zhang\n              D,\n            \n            \n              J\u00e4ggi\n              R,\n            \n            \n              Kuebler\n              WM.\n            \n          \n          The low-dose combination preparation Vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation.\n\t\t\t\t\tClin Hemorheol Microcirc.\n\t\t\t\t\t2010;46(1):23-35.\n\t\t\t\t\tDOI: 10.3233\/CH-2010-1330. PubMed PMID: 20852360.","DOI":"10.3233\/CH-2010-1330"},{"key":"2021012100102935000_i2168-9709-11-1-31-b11","unstructured":"Morawiec-Bajda\n              A,\n            \n            \n              Lukomski\n              M,\n            \n            \n              Latkowski\n              B.\n            \n          \n          The clinical efficacy of Vertigoheel in the treatment of vertigo of various etiology.\n\t\t\t\t\tPanminerva Med.\n\t\t\t\t\t1993;35(2):101-4.\n\t\t\t\t\tPubMed PMID: 8414621."},{"key":"2021012100102935000_i2168-9709-11-1-31-b12","doi-asserted-by":"crossref","unstructured":"Weiser\n              M,\n            \n            \n              Str\u00f6sser\n              W,\n            \n            \n              Klein\n              P.\n            \n          \n          Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study.\n\t\t\t\t\tArch Otolaryngol Head Neck Surg.\n\t\t\t\t\t1998;124(8):879-85.\n\t\t\t\t\tDOI: 10.1001\/archotol.124.8.879. PubMed PMID: 9708713.","DOI":"10.1001\/archotol.124.8.879"},{"key":"2021012100102935000_i2168-9709-11-1-31-b13","doi-asserted-by":"crossref","unstructured":"Issing\n              W,\n            \n            \n              Klein\n              P,\n            \n            \n              Weiser\n              M.\n            \n          \n          The homeopathic preparation Vertigoheel\u00ae versus ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial.\n\t\t\t\t\tJ Altern Complement Med.\n\t\t\t\t\t2005;11(1):155-60.\n\t\t\t\t\tDOI: 10.1089\/acm.2005.11.155. PubMed PMID: 15750375.","DOI":"10.1089\/acm.2005.11.155"},{"key":"2021012100102935000_i2168-9709-11-1-31-b14","doi-asserted-by":"crossref","unstructured":"Naranjo\n              CA,\n            \n            \n              Busto\n              U,\n            \n            \n              Sellers\n              EM,\n            \n            \n              Sandor\n              P,\n            \n            \n              Ruiz\n              I,\n            \n            \n              Roberts\n              EA,\n            \n            et al.\n\t\t\t\t\t\n          A method for estimating the probability of adverse drug reactions.\n\t\t\t\t\tClin Pharmacol Ther.\n\t\t\t\t\t1981;30(2):239-45.\n\t\t\t\t\tDOI: 10.1038\/clpt.1981.154. PubMed PMID: 7249508.","DOI":"10.1038\/clpt.1981.154"},{"key":"2021012100102935000_i2168-9709-11-1-31-b15","doi-asserted-by":"crossref","unstructured":"Sakurai\n              Y,\n            \n            \n              Takano\n              Y,\n            \n            \n              Kohjimoto\n              Y,\n            \n            \n              Honda\n              K,\n            \n          \n          Kamiya H-o. Enhancement of [3H]dopamine release and its [3H]metabolites in rat striatum by nicotinic drugs.\n\t\t\t\t\tBrain Res.\n\t\t\t\t\t1982;242(1):99-106.\n\t\t\t\t\tDOI: 10.1016\/0006-8993(82)90499-1. PubMed PMID: 6179571.","DOI":"10.1016\/0006-8993(82)90499-1"},{"key":"2021012100102935000_i2168-9709-11-1-31-b16","unstructured":"Medicinal Products Act in the version published on December 12, 2005 (Federal Law Gazette [BGBl.]). Part I p. 3394, last amended by Article 11 of the Act of May 6, 2019 (Federal Law Gazette I p. 646)."},{"key":"2021012100102935000_i2168-9709-11-1-31-b17","unstructured":"German homeopathic pharmacopoeia. Stuttgart: Medpharm Scientific Publishers;\n          2003."}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/11\/1\/31\/2713736\/i2168-9709-11-1-31.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/11\/1\/31\/2713736\/i2168-9709-11-1-31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:19:14Z","timestamp":1731687554000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/11\/1\/article-p31.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,8]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2021.01.031","relation":{},"ISSN":["2168-9709"],"issn-type":[{"type":"electronic","value":"2168-9709"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}